BACKGROUND: Cross-sectional studies suggest that the cognitive impact of Alzheimer disease pathology varies depending on education and brain size. OBJECTIVE: To evaluate the combination of cerebrospinal fluid biomarkers of β-amyloid(42) (Aβ(42)), tau, and phosphorylated tau (ptau(181)) with education and normalized whole-brain volume (nWBV) to predict incident cognitive impairment. DESIGN: Longitudinal cohort study. SETTING: Charles F. and Joanne Knight Alzheimer's Disease Research Center, Washington University, St Louis, Missouri. PARTICIPANTS: A convenience sample of 197 individuals 50 years and older with normal cognition (Clinical Dementia Rating of 0) at baseline observed for a mean of 3.3 years. MAIN OUTCOME MEASURE: Time to Clinical Dementia Rating ≥ 0.5. RESULTS: Three-factor interactions among the baseline biomarker values, education, and nWBV were found for Cox proportional hazards regression models testing tau (P = .02) and ptau (P = .008). In those with lower tau values, nWBV (hazard ratio [HR], 0.54; 95% confidence interval [CI], 0.31-0.91; P = .02), but not education, was related to time to cognitive impairment. For participants with higher tau values, education interacted with nWBV to predict incident impairment (P = .01). For individuals with lower ptau values, there was no effect of education or nWBV. Education interacted with nWBV to predict incident cognitive impairment in those with higher ptau values (P = .02). CONCLUSION: In individuals with normal cognition and higher levels of cerebrospinal fluid tau and ptau at baseline, time to incident cognitive impairment is moderated by education and brain volume as predicted by the cognitive/brain reserve hypothesis.
BACKGROUND: Cross-sectional studies suggest that the cognitive impact of Alzheimer disease pathology varies depending on education and brain size. OBJECTIVE: To evaluate the combination of cerebrospinal fluid biomarkers of β-amyloid(42) (Aβ(42)), tau, and phosphorylated tau (ptau(181)) with education and normalized whole-brain volume (nWBV) to predict incident cognitive impairment. DESIGN: Longitudinal cohort study. SETTING: Charles F. and Joanne Knight Alzheimer's Disease Research Center, Washington University, St Louis, Missouri. PARTICIPANTS: A convenience sample of 197 individuals 50 years and older with normal cognition (Clinical Dementia Rating of 0) at baseline observed for a mean of 3.3 years. MAIN OUTCOME MEASURE: Time to Clinical Dementia Rating ≥ 0.5. RESULTS: Three-factor interactions among the baseline biomarker values, education, and nWBV were found for Cox proportional hazards regression models testing tau (P = .02) and ptau (P = .008). In those with lower tau values, nWBV (hazard ratio [HR], 0.54; 95% confidence interval [CI], 0.31-0.91; P = .02), but not education, was related to time to cognitive impairment. For participants with higher tau values, education interacted with nWBV to predict incident impairment (P = .01). For individuals with lower ptau values, there was no effect of education or nWBV. Education interacted with nWBV to predict incident cognitive impairment in those with higher ptau values (P = .02). CONCLUSION: In individuals with normal cognition and higher levels of cerebrospinal fluid tau and ptau at baseline, time to incident cognitive impairment is moderated by education and brain volume as predicted by the cognitive/brain reserve hypothesis.
Authors: Anne M Fagan; Denise Head; Aarti R Shah; Daniel Marcus; Mark Mintun; John C Morris; David M Holtzman Journal: Ann Neurol Date: 2009-02 Impact factor: 10.422
Authors: Nina M Kemppainen; Sargo Aalto; Mira Karrasch; Kjell Någren; Nina Savisto; Vesa Oikonen; Matti Viitanen; Riitta Parkkola; Juha O Rinne Journal: Ann Neurol Date: 2008-01 Impact factor: 10.422
Authors: G Li; I Sokal; J F Quinn; J B Leverenz; M Brodey; G D Schellenberg; J A Kaye; M A Raskind; J Zhang; E R Peskind; T J Montine Journal: Neurology Date: 2007-08-14 Impact factor: 9.910
Authors: Brenna Cholerton; Adam Omidpanah; Tara M Madhyastha; Thomas J Grabowski; Astrid M Suchy-Dicey; Dean K Shibata; Lonnie A Nelson; Steven P Verney; Barbara V Howard; William T Longstreth; Thomas J Montine; Dedra Buchwald Journal: Alzheimer Dis Assoc Disord Date: 2017 Apr-Jun Impact factor: 2.703
Authors: Ge Li; Steven P Millard; Elaine R Peskind; Jing Zhang; Chang-En Yu; James B Leverenz; Cynthia Mayer; Jane S Shofer; Murray A Raskind; Joseph F Quinn; Douglas R Galasko; Thomas J Montine Journal: JAMA Neurol Date: 2014-06 Impact factor: 18.302
Authors: Rodrigo P Almeida; Stephanie A Schultz; Benjamin P Austin; Elizabeth A Boots; N Maritza Dowling; Carey E Gleason; Barbara B Bendlin; Mark A Sager; Bruce P Hermann; Henrik Zetterberg; Cynthia M Carlsson; Sterling C Johnson; Sanjay Asthana; Ozioma C Okonkwo Journal: JAMA Neurol Date: 2015-06 Impact factor: 18.302
Authors: Anja Soldan; Corinne Pettigrew; Qing Cai; Mei-Cheng Wang; Abhay R Moghekar; Richard J O'Brien; Ola A Selnes; Marilyn S Albert Journal: JAMA Neurol Date: 2016-06-01 Impact factor: 18.302
Authors: Jewell B Thomas; Matthew R Brier; Mario Ortega; Tammie L Benzinger; Beau M Ances Journal: Neurobiol Aging Date: 2014-06-21 Impact factor: 4.673